 |
Somatostatin |
|---|---|
| Trade Name | Zecnil |
| Orphan Indication | Adjunct to the non-operative management of secreting cutaneous fistulas of the stomach, duodenum, small intestine (jejunum and ileum), or pancreas |
| USA Market Approval | USA |
| USA Designation Date | 1988-06-20 00:00:00 |
| Sponsor | Ferring Laboratories, Inc.;400 Rella Boulevard, Suite 201;Suffern, New York, 10901 |
